These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 25164007)

  • 1. Ceramide kinase promotes tumor cell survival and mammary tumor recurrence.
    Payne AW; Pant DK; Pan TC; Chodosh LA
    Cancer Res; 2014 Nov; 74(21):6352-63. PubMed ID: 25164007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.
    Abravanel DL; Belka GK; Pan TC; Pant DK; Collins MA; Sterner CJ; Chodosh LA
    J Clin Invest; 2015 Jun; 125(6):2484-96. PubMed ID: 25961456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide Kinase Is Upregulated in Metastatic Breast Cancer Cells and Contributes to Migration and Invasion by Activation of PI 3-Kinase and Akt.
    Schwalm S; Erhardt M; Römer I; Pfeilschifter J; Zangemeister-Wittke U; Huwiler A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAQR8 promotes breast cancer recurrence and confers resistance to multiple therapies.
    Chen S; Paul MR; Sterner CJ; Belka GK; Wang D; Xu P; Sreekumar A; Pan TC; Pant DK; Makhlin I; DeMichele A; Mesaros C; Chodosh LA
    Breast Cancer Res; 2023 Jan; 25(1):1. PubMed ID: 36597146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular dormancy in minimal residual disease following targeted therapy.
    Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
    Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model.
    Shimizu Y; Furuya H; Tamashiro PM; Iino K; Chan OTM; Goodison S; Pagano I; Hokutan K; Peres R; Loo LWM; Hernandez B; Naing A; Chong CDK; Rosser CJ; Kawamori T
    Carcinogenesis; 2018 Jan; 39(1):47-55. PubMed ID: 28968647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transcriptional repressor Snail promotes mammary tumor recurrence.
    Moody SE; Perez D; Pan TC; Sarkisian CJ; Portocarrero CP; Sterner CJ; Notorfrancesco KL; Cardiff RD; Chodosh LA
    Cancer Cell; 2005 Sep; 8(3):197-209. PubMed ID: 16169465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer.
    Ruckhäberle E; Karn T; Rody A; Hanker L; Gätje R; Metzler D; Holtrich U; Kaufmann M
    J Cancer Res Clin Oncol; 2009 Aug; 135(8):1005-13. PubMed ID: 19125296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SPSB1 promotes breast cancer recurrence by potentiating c-MET signaling.
    Feng Y; Pan TC; Pant DK; Chakrabarti KR; Alvarez JV; Ruth JR; Chodosh LA
    Cancer Discov; 2014 Jul; 4(7):790-803. PubMed ID: 24786206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Imaging of Glucose Uptake and Mitochondrial Membrane Potential to Characterize Her2 Breast Tumor Metabolic Phenotypes.
    Madonna MC; Fox DB; Crouch BT; Lee J; Zhu C; Martinez AF; Alvarez JV; Ramanujam N
    Mol Cancer Res; 2019 Jul; 17(7):1545-1555. PubMed ID: 30902832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of cell survival by HUNK mediates breast cancer resistance to HER2 inhibitors.
    Yeh ES; Abt MA; Hill EG
    Breast Cancer Res Treat; 2015 Jan; 149(1):91-8. PubMed ID: 25515931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.
    Tarulli GA; De Silva D; Ho V; Kunasegaran K; Ghosh K; Tan BC; Bulavin DV; Pietersen AM
    Breast Cancer Res; 2013 Jan; 15(1):R10. PubMed ID: 23369183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of CERK and SPHK1 in breast cancer and their association with metastasis and drug resistance.
    Bhadwal P; Randhawa V; Vaiphei K; Dahiya D; Agnihotri N
    Sci Rep; 2022 Oct; 12(1):18239. PubMed ID: 36309544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of ceramide kinase on Rac1 activation, lamellipodium formation, cell migration, and metastasis of A549 lung cancer cells.
    Tomizawa S; Tamori M; Tanaka A; Utsumi N; Sato H; Hatakeyama H; Hisaka A; Kohama T; Yamagata K; Honda T; Nakamura H; Murayama T
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158675. PubMed ID: 32112978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.
    Kuwahara K; Yamamoto-Ibusuki M; Zhang Z; Phimsen S; Gondo N; Yamashita H; Takeo T; Nakagata N; Yamashita D; Fukushima Y; Yamamoto Y; Iwata H; Saya H; Kondo E; Matsuo K; Takeya M; Iwase H; Sakaguchi N
    Cancer Sci; 2016 Apr; 107(4):469-77. PubMed ID: 26749495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of increased osteopontin and splice variant-c mRNA expression with HER2 and triple-negative/basal-like breast carcinomas subtypes and recurrence.
    Ortiz-Martínez F; Perez-Balaguer A; Ciprián D; Andrés L; Ponce J; Adrover E; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G
    Hum Pathol; 2014 Mar; 45(3):504-12. PubMed ID: 24440093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The St. Gallen surrogate classification for breast cancer subtypes successfully predicts tumor presenting features, nodal involvement, recurrence patterns and disease free survival.
    Vasconcelos I; Hussainzada A; Berger S; Fietze E; Linke J; Siedentopf F; Schoenegg W
    Breast; 2016 Oct; 29():181-5. PubMed ID: 27544822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of sphingosine kinase 1 expression in feline mammary tumors.
    Chang YC; Chuang HL; Yin JH; Liao JW; Chen TH; Wang YC
    BMC Vet Res; 2019 May; 15(1):155. PubMed ID: 31101115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy.
    Caudle AS; Yu TK; Tucker SL; Bedrosian I; Litton JK; Gonzalez-Angulo AM; Hoffman K; Meric-Bernstam F; Hunt KK; Buchholz TA; Mittendorf EA
    Breast Cancer Res; 2012 May; 14(3):R83. PubMed ID: 22621334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer.
    Hergueta-Redondo M; Sarrio D; Molina-Crespo Á; Vicario R; Bernadó-Morales C; Martínez L; Rojo-Sebastián A; Serra-Musach J; Mota A; Martínez-Ramírez Á; Castilla MÁ; González-Martin A; Pernas S; Cano A; Cortes J; Nuciforo PG; Peg V; Palacios J; Pujana MÁ; Arribas J; Moreno-Bueno G
    Oncotarget; 2016 Aug; 7(35):56295-56308. PubMed ID: 27462779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.